Case Reports
9 November 2011
Vol. 63 No. 3 (2011)
https://doi.org/10.4081/reumatismo.2011.171

Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Splenic tuberculosis, ankylosing spondylitis, anti- TNF therapy
1052
Views
791
Downloads

Authors

V.F. Azevedo
valderilio@hotmail.com
Federal University of Paraná, .
E. Paiva
Federal University of Paraná, .
T. Tosin
Federal University of Paraná, .
A. Ferreira
Federal University of Paraná, Brazil.
A.M. Ferreira
Federal University of Paraná, .
M. Fernandes
Federal University of Paraná, .
We present a rare case of splenic tuberculosis in a 42-year old man with long-standing ankylosing spondylitis treated with adalimumab. We review the association between antitumor necrosis factor therapy and splenic tuberculosis. Our case, like many other reported cases, illustrates that the index of suspicion of tuberculosis in patients treated with anti TNF therapies must be high and emphasizes that this rare infection may occur even with negative tuberculosis screening before the initiation of therapy.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab. (2011). Reumatismo, 63(3), 171-174. https://doi.org/10.4081/reumatismo.2011.171

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.